Science Explorer Back to mapMap
Discussion

RxBio (United States)

Research works
3
▼ 100% vs 2018-21
Citations
104
30.1 per fractional work
Top-10% rate
6.4%
all institutions 10.0%
Open access
64%
world 40%
International
6%
world 18%

Not ranked overall: RxBio (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does RxBio (United States) work in?

In all years, 66% of research at RxBio (United States) is in Life Sciences, 31% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (57%), Medicine (26%), Neuroscience (9%). It does 1.5× the world's share of Life Sciences.

Life Sciences66%Physical Sciences3%Health Sciences31%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology257.1%
    2. Neuroscience08.6%
    1. Medicine125.7%
    2. Nursing05.7%
    1. Chemistry02.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from RxBio (United States)?

The most cited paper from RxBio (United States) is "The Lysophosphatidic Acid Type 2 Receptor Is Required for Protection Against Radiation-Induced Intestinal Injury" (Wenlin Deng, E Shuyu, Ryoko Tsukahara et al., 2007), with 122 citations. Next come "Combined Mitigation of the Gastrointestinal and Hematopoietic Acute Radiation Syndromes by an LPA2 Receptor-Specific Nonlipid Agonist" (44) and "Mitigation of the Hematopoietic and Gastrointestinal Acute Radiation Syndrome by Octadecenyl Thiophosphate, a Small Molecule Mimic of Lysophosphatidic Acid" (35).

Most cited papers
#PaperReleasedCitations
1 The Lysophosphatidic Acid Type 2 Receptor Is Required for Protection Against Radiation-Induced Intestinal Injury Wenlin Deng, E Shuyu, Ryoko Tsukahara et al. · Gastroenterology Open access 27 Mar 2007 122
2 Combined Mitigation of the Gastrointestinal and Hematopoietic Acute Radiation Syndromes by an LPA2 Receptor-Specific Nonlipid Agonist Renukadevi Patil, Erzsébet Szabó, James I. Fells et al. · Chemistry & Biology Open access 22 Jan 2015 44
3 Mitigation of the Hematopoietic and Gastrointestinal Acute Radiation Syndrome by Octadecenyl Thiophosphate, a Small Molecule Mimic of Lysophosphatidic Acid Wenlin Deng, Yasuhiro Kimura, Veeresh Gududuru et al. · Radiation Research Open access 25 Mar 2015 35
4 Structural Determinants of the Transient Receptor Potential 1 (TRPV1) Channel Activation by Phospholipid Analogs Sara L. Morales‐Lázaro, Bárbara Serrano‐Flores, Itzel Llorente et al. · Journal of Biological Chemistry Open access 18 Jul 2014 35
5 Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential Gábor Tigyi, Leonard R. Johnson, Sue Çhin Lee et al. · Journal of Lipid Research Open access 28 Jan 2019 27
All 10 most cited papers, with filters and sorting

Which research topics does RxBio (United States) publish most on?

By volume: Sphingolipid Metabolism and Signaling, Cell death mechanisms and regulation, Effects of Radiation Exposure and Drug Transport and Resistance Mechanisms.

  1. 1 Sphingolipid Metabolism and Signaling Molecular Biology 1 works
  2. 2 Cell death mechanisms and regulation Molecular Biology 0 works
  3. 3 Effects of Radiation Exposure Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Drug Transport and Resistance Mechanisms Oncology 0 works
  5. 5 Receptor Mechanisms and Signaling Molecular Biology 0 works
  6. 6 Lipid Membrane Structure and Behavior Molecular Biology 0 works
  7. 7 Lysosomal Storage Disorders Research Physiology 0 works
  8. 8 PARP inhibition in cancer therapy Oncology 0 works
  9. 9 Vitamin C and Antioxidants Research Nutrition and Dietetics 0 works
  10. 10 Genomics, phytochemicals, and oxidative stress Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available63.8%not open36.2%

World: 40% of research is openly available.

with international co-authors5.8%domestic only94.2%

World: 18% is written across borders.

How has RxBio (United States)'s research output changed?

Output in 2022-2025 was 100% lower than in 2018-2021.

20102015
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Johnson City

All research institutions in Johnson City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about RxBio (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.